-+ 0.00%
-+ 0.00%
-+ 0.00%

Sonoma Pharmaceuticals Q4 EPS $(0.48) Beats $(0.73) Estimate, Sales $3.75M Miss $4.44M Estimate

Benzinga·06/17/2025 20:12:52
Listen to the news
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.73) by 34.25 percent. This is a 65.47 percent increase over losses of $(1.39) per share from the same period last year. The company reported quarterly sales of $3.75 million which missed the analyst consensus estimate of $4.44 million by 15.45 percent. This is a 9.16 percent increase over sales of $3.44 million the same period last year.